Covis Pharma is a global specialty pharmaceutical company that focuses on providing therapeutic solutions for patients with life-threatening conditions and chronic illnesses. With a strong and experienced senior management team, Covis is dedicated to improving the lives of its patients by delivering affordable and therapeutically equivalent medications. Through strategic partnerships with world-class pharmaceutical companies and contract manufacturing organizations, Covis ensures operational excellence and offers a diverse portfolio of pharmaceutical products in over 50 countries.
Founded in 2011 and backed by private equity sponsor Apollo Global Management, Covis Pharma has a history of successful acquisitions, including the global rights for Alvesco, Omnaris, and Zetonna. The company continues to strengthen its global respiratory portfolio through strategic acquisitions, such as the recent acquisition of two medicines from AstraZeneca. Covis Pharma's mission is to tap into untapped potential and develop innovative medical therapies that make a positive impact on the lives of patients worldwide.
Generated from the website